Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Savic

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Clinical and Experimental Dermatology|April 5, 2020
Chronic urticaria in the real-life clinical practice setting in the UK: results from the noninterventional multicentre AWARE studyS Savic, L Leeman, T El-Shanawany, et al.
Clinical and Experimental Immunology|September 5, 2012
Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patientsL R Coulthard, J Geiler, R J Mathews, et al.
Annals of the Rheumatic Diseases|December 19, 2007
A novel TNFRSF1A splice mutation associated with increased nuclear factor kappaB (NF-kappaB) transcription factor activation in patients with tumour necrosis factor receptor associated periodic syndrome (TRAPS)S M Churchman, L D Church, S Savic, et al.
ESMO Open|July 13, 2023
Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14D König, S Savic Prince, S Hayoz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 15, 2025
A randomised phase III study of bevacizumab and carboplatin-pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trialE Felip, S Popat, U Dafni, et al.
Oncotarget|December 29, 2016
Genomic regulation of invasion by STAT3 in triple negative breast cancerJoy M McDaniel, Katherine E Varley, Jason Gertz, et al.
British Journal of Anaesthesia|April 29, 2019
Consensus clinical scoring for suspected perioperative immediate hypersensitivity reactionsP M Hopkins, P J Cooke, R C Clarke, et al.
British Journal of Anaesthesia|March 28, 2019
Management of a surgical patient with a label of penicillin allergy: narrative review and consensus recommendationsL C Savic, D A Khan, P Kopac, et al.
Clinical and Experimental Immunology|June 8, 2018
The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017B Shillitoe, C Bangs, D Guzman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 30, 2017
Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape ProjectK M Kerr, U Dafni, K Schulze, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Clinical and Experimental Dermatology|April 5, 2020
Chronic urticaria in the real-life clinical practice setting in the UK: results from the noninterventional multicentre AWARE studyS Savic, L Leeman, T El-Shanawany, et al.
Clinical and Experimental Immunology|September 5, 2012
Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patientsL R Coulthard, J Geiler, R J Mathews, et al.
Annals of the Rheumatic Diseases|December 19, 2007
A novel TNFRSF1A splice mutation associated with increased nuclear factor kappaB (NF-kappaB) transcription factor activation in patients with tumour necrosis factor receptor associated periodic syndrome (TRAPS)S M Churchman, L D Church, S Savic, et al.
ESMO Open|July 13, 2023
Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14D König, S Savic Prince, S Hayoz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 15, 2025
A randomised phase III study of bevacizumab and carboplatin-pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trialE Felip, S Popat, U Dafni, et al.
Oncotarget|December 29, 2016
Genomic regulation of invasion by STAT3 in triple negative breast cancerJoy M McDaniel, Katherine E Varley, Jason Gertz, et al.
British Journal of Anaesthesia|April 29, 2019
Consensus clinical scoring for suspected perioperative immediate hypersensitivity reactionsP M Hopkins, P J Cooke, R C Clarke, et al.
British Journal of Anaesthesia|March 28, 2019
Management of a surgical patient with a label of penicillin allergy: narrative review and consensus recommendationsL C Savic, D A Khan, P Kopac, et al.
Clinical and Experimental Immunology|June 8, 2018
The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017B Shillitoe, C Bangs, D Guzman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 30, 2017
Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape ProjectK M Kerr, U Dafni, K Schulze, et al.
Pageof 7